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Abstract
To better understand the role of individual and lifestyle factors in human disease, an
exposome-wide association study was performed to investigate within a single-study
anthropometry measures and lifestyle factors previously associated with B-cell lym-
phoma (BCL). Within the European Prospective Investigation into Cancer and nutri-
tion study, 2402 incident BCL cases were diagnosed from 475 426 participants that
were followed-up on average 14 years. Standard and penalized Cox regression
models as well as principal component analysis (PCA) were used to evaluate 84 expo-
sures in relation to BCL risk. Standard and penalized Cox regression models showed a
positive association between anthropometric measures and BCL and multiple mye-
loma/plasma cell neoplasm (MM). The penalized Cox models additionally showed the
association between several exposures from categories of physical activity, smoking
status, medical history, socioeconomic position, diet and BCL and/or the subtypes.
PCAs confirmed the individual associations but also showed additional observations.
The PC5 including anthropometry, was positively associated with BCL, diffuse large
B-cell lymphoma (DLBCL) and MM. There was a significant positive association
between consumption of sugar and confectionary (PC11) and follicular lymphoma
risk, and an inverse association between fish and shellfish and Vitamin D (PC15) and
2 SABERI HOSNIJEH ET AL.
Cancer Aid; German Cancer Research Center
(DKFZ); German Federal Ministry of Education
and Research, Grant/Award Number: BMBF
01EO1303; German Institute of Human
Nutrition Potsdam-Rehbruecke, Nuthetal
(Germany); Institut Gustave Roussy; Institut
National de la Sante et de la Recherche
Medicale (France); International Agency for
Research on Cancer; Ligue Natinale Contre le
Cancer; LK Research Funds; Medical Research
Council, Grant/Award Numbers: 1000143
(to EPIC-Norfolk), MR/M012190/1 (to EPIC-
Oxford); Mutuelle Generale de l'Education
Nationale; Netherlands Cancer Registry (NKR);
Nordforsk, Nordic Centre of Excellence
programme on Food, Nutrition and Health
(Norway); Spanish Ministry of Economy and
Competitiveness - Carlos III Institute of Health
cofunded by FEDER funds/European Regional
Develpment Fund (ERDF) - a way to build
Europe, Grant/Award Numbers: PI13/00061
(to Granada), PI13/01162 (to EPIC-Murcia),
PI17/01280, PI14/01219 (to Barcelona);
Statistics Netherlands (The Netherlands),
Grant/Award Number: Grant number:
ERC2009-AdG 232997; Swedish Cancer
Society; Swedish Research Council and County
Councils of Skåne and Vasterbotten (Sweden);
the Hellenic Health Foundation (Greece);
Wellcome Trust, Grant/Award Number:
205212/Z/16/Z; World Cancer Research Fund
(WCRF)
DLBCL risk. The PC1 including features of the Mediterranean diet and diet with
lower inflammatory score showed an inverse association with BCL risk, while the
PC7, including dairy, was positively associated with BCL and DLBCL risk. Physical
activity (PC10) was positively associated with DLBCL risk among women. This study
provided informative insights on the etiology of BCL.
K E YWORD S
exposome, exposome-wide association study, lifestyle, lymphoma, prospective study
1 | INTRODUCTION
B-cell lymphomas (BCLs) are an etiologically, clinically, and histologically
heterogeneous group of malignant diseases of B lymphocytes. Immuno-
deficiency and autoimmunity are strong B-cell lymphoma risk factors.1
Epidemiological studies showed that the risk of BCL is associated with
anthropometry measures, lifestyle, viral, environmental and occupational
factors (collectively called the exposome).2-8 Moreover, in the last two
decades, reports from epidemiological studies suggested differences in
risks among BCL subtypes for a wide range of risk factors.2
To better understand the role of risk factors in the occurrence of
BCL, it would be preferable to study a large set of lifestyle factors
(exposome) in a single study. Few methods are available to comprehen-
sively evaluate the role of specific risk factors with disease. Recently, a
study design analogous to genome-wide association studies, the
exposome-wide association study, or equivalently, environment-wide
association study (EWAS), has been proposed to search for and validate
exposures associated with complex diseases. Instead of testing one or
only a few associations at a time, EWAS evaluates multiple exposures for
association, with proper adjustment for multiplicity and collinearity of
comparisons. EWAS techniques have recently been used to assess envi-
ronmental factors in relation to chronic diseases (eg, Type 2 diabetes,
high blood pressure and peripheral arterial disease) and mortality.9-11
In this study, we aimed to use an exposome-wide approach to evalu-
ate multiple lifestyle exposures and determine both their independent
and combined roles (using a multivariable penalized regression algorithm
and principal component [PC] approaches) with respect to the risk of
BCL and major subtypes using data from the European Prospective
Investigation into Nutrition and Cancer cohort (EPIC).
2 | MATERIALS AND METHODS
The EPIC study is a prospective cohort involving 23 centers from10 European
countries (Denmark, France, Germany, Greece, Holland, Italy, Norway, United
Kingdom, Spain and Sweden). The rationale and study design have been
described previously.12,13 In brief, 521 324 subjects, mostly aged 30 to
70 years, were recruited between 1992 and 2000. Ethical review boards from
International Agency for Research on Cancer (IARC) and local participating
centers approved the study and all participants gave their written informed
consent. Of the 521 324 EPIC cohort participants, we excluded prevalent
cancer cases at baseline (n = 25 184), subjects with missing follow-up infor-
mation (n = 4148), with incomplete information on diet or lifestyle question-
naires (n = 6259), or those with extreme caloric intake (top and bottom 1% of
the total energy intake to energy requirement ratio) (n = 9573) and incident
cases of non-BCL lymphomas (n = 734). This left a cohort of 475 426 sub-
jects, including 2402 incident BCL and 473 024 participants free of cancer.
Validated country-specific questionnaires were used to collect infor-
mation on the usual diet during the year before recruitment; namely
through self-administered semi-quantitative food frequency question-
naires or diet history questionnaires administered through a personal
interview, and semi-quantitative food-frequency questionnaires
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combined with a food record.13,14 Lifestyle questionnaires were used to
obtain information on sociodemographic characteristics, physical activity,
medical history and alcohol and tobacco consumption. Anthropometric
measures were also ascertained at recruitment.15
2.1 | Follow-up and outcome assessment
Primary incident lymphoma cancer cases were identified by linkage
with national cancer registries in Denmark, Italy, the Netherlands,
Norway, Spain, Sweden and the United Kingdom. A combination of
methods were used in France, Germany and Greece, including cancer
registries, health insurance records, and active follow-up contacting
participants or their next-of-kin. Mortality data were retrieved from
regional or national mortality registries. The follow-up period was
defined from the age at recruitment to the age at first lymphoma diag-
nosis, death or last complete follow-up (December 31, 2013),
depending on which occurred first.
Diagnoses of primary incident lymphoma cases were based on
the International Classification of Diseases for Oncology, third edition
and grouped according to recommendations of the InterLymph
Pathology Working Group.1 In the current analysis, only mature B-cell
lymphomas (Table S1) were considered, which were further catego-
rized into diffuse large B-cell lymphoma (DLBCL), follicular lymphoma
(FL), chronic lymphocytic leukemia (CLL) (including small lymphocytic
leukemia), multiple myeloma/plasma cell neoplasm (MM), and “other”
entities (ie, those cases in which the B-cell lymphoma subtype is
unknown or does not fall within the above-mentioned subtypes).
2.2 | Exposures assessment per category
Anthropometry measures included height, weight, hip circumference,
waist circumference, body mass index (BMI, kg/m2) and waist to hip
ratio. Participants' height, weight, hip circumference and waist circumfer-
ence were measured at baseline, except for France, Oxford and Norway,
where self-reported measures were obtained via questionnaire.15-17
Smoking status included ever smoking, current smoking, currently
smoking cigarettes, currently smoking cigars, duration of smoking,
duration of cigarettes smoking, >15/d currently smoked cigarettes
and >25/d currently smoked cigarettes.
Alcohol intake: Data on alcohol intake were collected through the die-
tary questionnaire (alcohol intake over 12 months prior to recruitment) and
in the lifestyle questionnaire (consumption of alcoholic beverages at differ-
ent ages in the past) and expressed in grams of ethanol per day (g/d).
Medical history: Participants stated whether they had ever had
myocardial infarction, stroke, hypertension, diabetes, reported a car-
diovascular problem.
Physical activity: The assessment of physical activity measures is
described in detail elsewhere.18-20 Current occupational physical
activity was based on employment status and on the level of physical
activity at current work, which was later coded in categories (seden-
tary occupation, standing occupation, manual work, heavy manual
work and unemployed). Information on housework, do-it-yourself
work, gardening and climbing stairs was combined to estimate the
overall household activities and walking, cycling and sport activities
were combined to determine the overall recreational activities. Subse-
quently, energy expenditure using metabolic equivalent values was
calculated, according to the Compendium of Physical Activities.21
Sex-specific total physical activity index, Cambridge physical activity
index (1-4 levels) and IARC physical activity score (1-3 levels) were
also included in current analyses.
Diet: The 16 main food groups included were potatoes and other
tubers; vegetables; legumes; fruits (including nuts and seeds); dairy
products; cereal and cereal products; meat and meat products; fish
and shellfish; egg and egg products; fat; sugar and confectionary;
cakes and biscuits; nonalcoholic beverages; alcoholic beverages; con-
diments and sauces; soups and bouillons.
Nutrient: Nutrient values of all items from the 24-hour dietary
recalls were standardized to build the EPIC Nutrient Database.22 For
each nutrient, the nutrient density was calculated by dividing the calo-
ric value of that nutrient by the total caloric intake. For nutrients with-
out caloric value (vitamins, flavonoids, cholesterol, calcium), the
weight of the nutrient was divided by the total caloric intake.
Dietary pattern: The Mediterranean diet (MD) score was assessed
using the adapted relative MD (arMED) score.23,24 In brief, the arMED
is a 16-point linear score that incorporates eight key dietary compo-
nents: six components presumed to reflect the MD [fruit (including
nuts and seeds), vegetables, legumes, fish (including seafood), olive oil
and cereals] and two components consumed in low quantity in the
MD (dairy products and meat). The sum of these points was used to
define the MED score, that ranged from 0 to 16 (from the lowest to
the highest adherence).24 The dietary inflammatory potential was
assessed by means of an inflammatory score of the diet (ISD), calcu-
lated using 28 dietary components and their corresponding inflamma-
tory weights.25,26 Overall, the ISD is a relative index that categorizes
individual's diets from maximally anti-inflammatory (corresponding to
lower scores) to maximally pro-inflammatory (higher values).
Socioeconomic position (SEP): Educational level (primary school or
less, technical/professional school, secondary school, longer education
including university degree) was used as an indirect measure of SEP. A
particular advantage of investigating education is avoiding reverse
causation bias: diseases may lead to downward occupational mobility
and reduced income, but generally will not affect educational status
achieved by early adulthood.
2.3 | Statistical analyses
Table S2 shows the list of 84 exposure variables included in the study.
Exposure variables with <25% missing data (Table S3) were imputed
based on a maximum likelihood estimation method which was
informed by the observed correlation structure within the data. To
understand the structure of our data and see which exposures are
related to each other, we calculated Spearman rank correlation
between each two variables adjusted for age, sex and country.
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Spearman correlation coefficients were visualized with a heatmap
where variables were arranged using a hierarchical clustering algo-
rithm. The larger the correlation between a pair of variables, the closer
in proximity they appear in the heatmap. Absolute correlations below
0.2 were omitted and remaining correlations were plotted in a
“circus” plot.
Univariate and age-, sex-, and country-adjusted Cox proportional
hazards models were used to examine the association between each
exposure and BCL and its subtypes. Subsequently, to examine country
heterogeneity, we fitted each model per country (age and sex
adjusted) and pooled the estimates by conducting a random-effects
meta-analysis. The coefficient of inconsistency I2 was used as a metric
to assess heterogeneity between countries, with a P value <.05 to be
regarded as statistically significant evidence for between country het-
erogeneity. Cox analyses were stratified by sex and median age at
recruitment (≤55, >55 years). Sensitivity analyses were performed by
excluding cases with less than 2 years of follow-up (n = 176 cases)
and centers with self-reported anthropometry data (France, Oxford
and Norway) and without comprehensive physical activity data
(Norway, Umea).
Given the correlation between exposures, univariate regression
analysis is prone to increased false positive results.27 Therefore, we
used the least absolute shrinkage and selection operator (LASSO)
technique, a multivariable penalized regression algorithm,28,29 to iden-
tify exposures associated with BCL. LASSO technique is a powerful
method that performs two main tasks: regularization and feature
selection. In order to do so, the method applies a shrinking (regulariza-
tion) process in which the coefficients of the regression variables are
penalized, thus shrinking some of them to zero. During the feature
selection process, the variables that still have a nonzero coefficient
after shrinkage are selected to be part of the model. Optimal tuning
parameter λ, which controls the strength of the penalty, was obtained
by 5-fold cross-validation. All exposures were standardized. Dummy
variables were defined for country and together with age and sex
were forced into the “regularized” Cox model by decreasing their pen-
alty factor to zero. We also applied an Elastic-Net approach29 that
combines the penalties of ridge and LASSO regressions to get the best
of both. The method effectively shrinks coefficients (similar to ridge
regression) and set some coefficients to zero, like in LASSO. As the
results were similar to the LASSO technique, we therefore present
the former.
Finally, PC analysis (PCA) was applied to reduce the spectrum of
the exposures into a smaller number of clusters of related exposures.
Varimax orthogonal rotation method was performed for PCA ensuring
absence of redundancy, and component scores were calculated for
each individual. Components with eigenvalue >1 were included. age-,
gender-, country-adjusted Cox regression was performed on B-cell
lymphoma status for all PCs separately and collectively. Moreover,
Cox analyses were stratified by sex and median age at recruitment
(≤55, >55 years).
Statistical analyses were performed using the R 3.4.1 language
and environment (The R Foundation for Statistical Computing, Vienna,
Austria) and IBM SPSS Statistics 25. Statistical P values were two
sided and were corrected for multiple testing using false discovery
rate (FDR) method.
3 | RESULTS
After an average of 13.94 years follow-up (SD = 4.03, median = 14.86),
2402 participants developed BCL. Of all BCL cases, 22.4% (n = 537)
were diagnosed with CLL, 15.9% (n = 381) with FL, 20.3% (n = 488)
with DLBCL, and 28.1% (n = 676) with MM (Table 1). Subjects diag-
nosed with BCL were more likely to be older, less educated and over-
weight (higher BMI) at recruitment as compared with the whole
population. The percentage of male participants was higher in cases
than in the whole population (42.6 vs 29.8, respectively). Distribution
of BCL subtypes across countries is shown in Table S4.
TABLE 1 General characteristics of study population
Whole
cohort BCL
Size, n 475 426 2402
Age, mean (SD) 51.2 (9.94) 55.7 (8.10)
Female (%) 70.2 57.4
BMI, mean (SD) 25.4 (4.27) 25.97
(4.24)
Education (%)
None/primary school 30.3 35.1
Technical/professional school 23.8 27.5
Secondary school 21.0 15.7







United Kingdom 15.8 17.7












Abbreviations: BMI, body mass index; CLL, chronic lymphocytic leukemia/
small lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; FL,
follicular lymphoma; MM, plasma cell neoplasm/multiple myeloma.
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3.1.1. | Data correlation structure
Means and medians for exposures in continuous scale and frequencies
for exposures in categories are given in Table S2 for the total study
population. A large part (87.9%) of absolute correlations between
exposures were lower than 0.4 (Figure S1). As expected, correlated
exposures were mostly within the same category (Figure S2).
3.1.2. | Standard Cox regression
In a first set of analyses, all BCL cases were pooled together and
univariable and multivariable Cox regression models adjusted for age,
gender and country were performed for each exposure. Results of the
univariable models are shown in Table S5. In multivariable models, for
BCL, three anthropometry measures reached the significance level
after multiple testing correction (Figure 1), namely, height (β = .014, P
value = 2.16E-05, pFDR = 0.002), weight (β = .007, P values = 8.26E-
05, pFDR = 0.003) and hip circumference (β = .010, P values = .0003,
pFDR = 0.009).
The analyses for histological subtype did not show any significant
associations between the included exposures and CLL and DLBCL
(Figure 1). In contrast, we identified two positive associations for MM
(Figure 1) including weight (β = .012, P value = 8.86E-05,
pFDR = 0.007) and hip circumference (β = .017, P value = 0.0006,
pFDR = 0.02). BMI (β = .031, P value = .0008, pFDR = 0.03) was sig-
nificantly associated with MM. Moreover, consumption of sugar and
confectionary (β = .002, P value = .0002, pFDR = 0.02) was associated
with an increased hazard of FL (Table S6, lower panel).
Next, Cox regression analyses were performed for each country
independently and per-country estimates were pooled (random effect
meta-analysis). Among anthropometry variables, height was associ-
ated with increased risk of BCL after multiple testing corrections
(Figure 3). We found similar results for MM without significant het-
erogeneity between countries while the association between con-
sumption of sugar and confectionary and FL risk was no longer
statistically significant (β = .004, P value = .01, P heterogeneity = .06)
(Figure S3, Table S6, upper panel). In addition, weight (β = .013, P
value = .0006), currently smoking >25/d (β = .92, P value = .001) and
manual work (β = .42, P value = .002) were positively associated with
risk of DLBCL.
The reported associations between BCL, FL, DLBCL and MM and
several exposures differed by sex and age (≤55 years, >55 years)
(Table S7). The associations between height and weight and BCL,
weight and DLBCL and consumption of sugar and confectionary and
FL were present among women.
3.1.3. | Penalized Cox regression
LASSO models confirmed the reported findings of the standard Cox
model for BCL and the subtypes and selected additional exposures
associated to BCL and/or DLBCL (Table 2). Intake of dairy products,
total fats with animal origin, physical activity, manual work, currently
smoking >25/d and history of myocardial infarction were positively
associated with risk of BCL and/or DLBCL while intake of condiments
and sauces, polyunsaturated fatty acids, fruit, nuts and seeds, Vitamin





















































































































































































































































































































































































































































































































































































































































































































































































































































F IGURE 1 Standard Cox regression for individual exposure adjusted for country, age and sex in total BCL and subtypes. Vertical axis shows
the −Log10 p FDR value and blue line shows pFDR = 0.05. See Table S2 for name, type and unit of the exposures. BCL, B-cell lymphoma; FDR,
false discovery rate [Color figure can be viewed at wileyonlinelibrary.com]
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occupation, education, current smoker and currently smoke cigars
were negatively associated with risk of BCL and/or DLBCL.
3.1.4. | Principal component analysis
To investigate how the exposures might have a combined effect, we
used PCA. The exposures in total population were merged into
22 PCs with eigenvalue>1 explaining 78.5% of the data variation
(Figure 2, Table S8). As shown in Figure 2, all exposures were corre-
lated with one of the PCs without much overlap. In multivariable Cox
models adjusted for age, sex and country, we found six PCs (PC5,
PC7, PC10, PC11, PC12 and PC15) reached to significance of 0.05 in
relation to BCL and/or subtypes, among which PC5 including anthro-
pometry measures was significant after multiple testing correction
(Table S9). Multivariable Cox models mutually adjusted for other PCs
essentially showed the same PCs, except for PC12, which was charac-
terized by high water and nonalcoholic beverage consumption and no
longer associated with MM after mutual adjustment for other PCs
(Table 3). Moreover, we found a lower risk of BCL related to PC1,
which includes certain dietary features of the MD and diet with
lower inflammatory score. PC15 including consumption of fish,
shellfish and Vitamin D showed a protective effect on DLBCL while
consumption of dairy products, calcium and phosphorus (PC7) were
related to increased risk of BCL and DLBCL. The PC10 involving
physical activity variables was associated with increased risk of
BCL and DLBCL. Higher consumption of sugar, confectionery and
carbohydrate products (PC11) increased FL risk. Majority of the
selected exposures by LASSO were among those present in the sig-
nificant PCs. This indicates that these individual exposures were
actually part of a broader construct and should be interpreted in
that context.
The stratified analyses revealed that the associations between
BCL and the subtypes and certain PCs slightly differ between males
and females (Table 4) and by age (Table S10). These analyses showed
a positive association between PC5, PC7, PC10, PC11, PC12 and
TABLE 2 Regression coefficient of the selected exposures by LASSO model for total BCL and major subtypes
BCL CLL FL DLBCL MM
Exposure PC Estimate Estimate Estimate Estimate Estimate
Height 16 0.008
Weight 5 0.001 0.005 0.004
Hip circumference 5 0.004 0.001
Fruit, nuts, and seeds 1 −0.000002
Dairy products 7 0.0001 0.0002
Sugar and confectionary 11 0.00002 0.001
Condiments and sauces 17 −0.001 −0.0001
Total polyunsaturated fatty acids 6 −0.002
Total fats, animal origin 2 0.002
Vitamin D 15 −0.016
Retinol 19 −0.00002
Current smoker 3 −0.044
Currently smoking >25/day 18 0.330
Currently smoking cigars 19 −0.030
Total physical activity index (sex-specific) (Active) 10 0.022 0.141
Manual work 10 0.082 0.122
Recreational activity (METS) 8 0.0003
Standing occupation 20 −0.040
Hypertension 14 −0.042
Myocardial infarction 21 0.182
Stroke 21 −0.010
Education 16 −0.010
Note: Country, age and gender were forced into the penalized Cox models. All variables were standardized. Penalty parameter, lambda, was derived using
5-fold cross-validation. Regression coefficients were obtained at lambda minimum (the value of λ at the lowest cross-validation error). Positive coefficients
indicate that an exposure is associated with higher risk of lymphoma, and vice versa for negative coefficients. See Table S2 for name, type and unit of the
exposures.
Abbreviations: BCL, B-cell lymphoma; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; FL, follicular
lymphoma; METS, Metabolic Equivalent of Task/week; MM, plasma cell neoplasm/multiple myeloma; PC, principal component.
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PC13 and DLBCL and between PC9, PC11, PC13 and FL among
women.
Exclusion of cases diagnosed in the first 2 years of follow-up
(n = 176) did not materially alter the estimates for individual expo-
sures and PCs. Moreover, sensitivity analyses excluding centers with
self-reported anthropometry data and centers without comprehensive
physical activity data (n = 178 106) did not change the reported asso-
ciation between anthropometry and BCL and MM, and between phys-
ical activity and BCL and DLBCL (data not shown).
4 | DISCUSSION
In this large prospective cohort study, several anthropometric mea-
sures and lifestyle factors were associated with BCL and/or subtypes,
with strong evidence for a positive association of anthropometric
measures.
In our study, we used a new exposome-based approach to find
risk factors of BCL. It consisted of four analytical parts: investigating
the data structure, standard and penalized Cox regression methods to
find exposures robustly associated to the risk of BCL, and a PCA to
see how the exposures are related. A multivariable penalized regres-
sion analysis, like LASSO, is preferable over a regression model con-
sidering each individual exposure variable separately, since LASSO has
been previously shown to have a more favorable tradeoff between
sensitivity and the false discovery proportion in exposome data.27,30
With LASSO, a model is created where the effect of each exposure is
adjusted for the effect of other associated exposures, while penalizing
the nonassociated exposures to null. It has been shown that in the
presence of correlated influential variables, LASSO will select at most
one of them.30 Associated exposures are penalized to zero or even
show a reverse association. Therefore, we also performed PCA to
investigate which exposures are correlated and have potentially a
combined effect.
Several anthropometry variables reflecting obesity (ie, weight, hip
circumference, and BMI) as well as height were positively associated
with BCL and/or subtypes in our study and previous investiga-
tions.2,31-33 There are several potential mechanisms whereby obesity
may increase the risk of BCL. Impaired immune function, chronic
inflammatory response, effects on cell proliferation and changes in
the metabolism of endogenous hormones, leading to a distortion in
the normal balance between cell proliferation, differentiation and apo-
ptosis are some of the postulated putative biological mecha-
nisms.2,31,33 Height per se does not cause cancer, but could act as a
marker for genotype or environmental exposures that could influence
immune system function.33,34 Height is a proxy for cell division and
total cell reservoir. Larger bodies contain more cells than smaller bod-
ies and therefore have a greater chance that a cell will undergo malig-
nant transformation, escape the body's cancer defense mechanisms,
and progress to cancer.33 Moreover, height might be related to cancer
risk through increased cell turnover mediated by growth factors.33
Based on epidemiologic reports, there is growing evidence that
diet plays a role in lymphomagenesis although the data for BCL sub-
types are scarce. This study provides more support for the role of
nutrition in lymphoma. In our study, consumption of sugar, confec-
tionary, and carbohydrates products was associated with increased
risk of FL, particularly among female participants. The majority of pre-
vious prospective and case-controls studies on total carbohydrates or






























































































F IGURE 2 A heatmap for the correlation of each exposure with
each principal component. The color of the intersection of an
exposure (vertical axis) and a principal component (horizontal axis)
indicates the dimension of the correlation: dark blue indicates a highly
negative correlation; dark red indicates a highly positive correlation;
The staircase-like high correlation line in the figure indicates that all
exposures are correlated with one of the principal components
without much overlap. See Table S2 for name, type and unit of the
exposures [Color figure can be viewed at wileyonlinelibrary.com]
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except a positive association reported between high consumption of
white bread or pasta and non-Hodgkin lymphoma (NHL).35 Although
sugar intake was not associated with NHL,36 in a follow-up study,
women who frequently consumed cakes or pies were associated with
an elevated risk for NHL.37 Studying dietary glycemic index and glyce-
mic load in further studies are warranted to clarify this association.38
We found that consumption of dairy products, calcium, riboflavin
(B2) and phosphorus may increase the risk of BCL and DLBCL, in par-
ticular among females. Previous studies suggested a positive associa-
tion between dairy products and risk of NHL,39,40 particularly for
DLBCL.41 Milk is a source of fat and protein, which are both thought
to be risk factors for NHL,39 as well as calcium, riboflavin and
Vitamin A.35 The positive association between dairy consumption and
risk of BCL may be attributed to the effects of dietary calcium and
phosphorus, largely found in dairy products, which decrease levels of
1,25(OH)2 Vitamin D [1,25(OH)2D]. 1,25(OH)2 D, the physiologically
active form of Vitamin D, is considered an anticarcinogen because it
promotes differentiation and apoptosis and inhibits cell growth in
preneoplastic and neoplastic cells. Moreover, association between
Vitamin D3 and autophagy and activation of antibacterial peptides
have been reported.42,43 Although a recent pooled study did not
support the hypothesis that elevated circulating Vitamin D [25(OH)D]
concentration is associated with a reduced risk of NHL,44 another
study suggested that 25(OH)D insufficiency was associated with infe-
rior survival in DLBCL and T-cell lymphoma.45 Another mechanism
involves presence of organochlorines such as dioxins and poly-
chlorinated biphenyls in dairy fat, which are well-known human car-
cinogens and immunotoxins and can alter normal B-cell responses.
Finally, bovine leukemia virus associated with lymphosarcoma in cattle
may be transmitted through milk to humans, although there is no clear
evidence of human infection.
Our study also suggested a possible inverse association between
consumption of fish, shellfish and Vitamin D and the risk of DLBCL.
Previous reports on fish consumption and risk of lymphoma have
yielded inconsistent findings. Possible reasons for discrepancies
across studies may reflect varying levels of organochlorine pesticides
and polychlorinated biphenyls compounds that have been associated
with increased risk of NHL. Thus, adverse health effects related to
their high content in some fish may diminish the otherwise protective
effects conferred by fish consumption.39
We found a possible association between the consumption of
animal fats (positive association) and polyunsaturated fatty acids
TABLE 3 Multivariable HRs and 95% CIs of the PCs for total BCL and major subtypes mutually adjusted for other PCs
BCL CLL FL DLBCL MM
PC HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
1 0.94 (0.89-0.99) .03 0.94 (0.84-1.05) .26 0.96 (0.84-1.10) .58 0.97 (0.87-1.10) .66 0.91 (0.82-1.01) .08
2 1.03 (0.98-1.08) .27 1.10 (0.99-1.21) .07 0.97 (0.85-1.10) .63 0.98 (0.88-1.10) .79 1.01 (0.92-1.10) .91
3 0.99 (0.95-1.03) .65 0.99 (0.90-1.08) .75 0.94 (0.85-1.05) .31 1.01 (0.92-1.11) .78 0.99 (0.91-1.07) .82
4 1.03 (0.99-1.08) .17 1.00 (0.91-1.11) .95 1.02 (0.91-1.15) .73 0.99 (0.90-1.11) .94 1.06 (0.98-1.16) .16
5 1.09 (1.04-1.15) .0001 1.06 (0.96-1.18) .25 1.02 (0.89-1.16) .78 1.15 (1.03-1.28) .01 1.18 (1.07-1.29) .0001
6 1.00 (0.95-1.05) .97 0.91 (0.81-1.02) .10 0.94 (0.82-1.08) .42 0.96 (0.85-1.08) .48 1.06 (0.96-1.16) .25
7 1.04 (1.00-1.09) .04 1.01 (0.92–1.10) .89 1.09 (0.98-1.20) .11 1.12 (1.03-1.22) .01 1.02 (0.94-1.10) .62
8 1.00 (0.96-1.05) .90 0.98 (0.89-1.07) .61 0.95 (0.85-1.06) .39 1.05 (0.95-1.15) .33 1.00 (0.92-1.08) .95
9 1.03 (0.99-1.07) .20 1.04 (0.96-1.14) .31 1.08 (0.97-1.20) .15 1.02 (0.93-1.12) .67 0.98 (0.90-1.06) .62
10 1.06 (1.02-1.11) .01 1.07 (0.98-1.17) .14 1.10 (0.98-1.22) .10 1.12 (1.02-1.22) .02 1.07 (0.98–1.16) .13
11 1.04 (0.99–1.08) .07 0.98 (0.90-1.08) .74 1.13 (1.03-1.25) .01 1.06 (0.97-1.16) .18 1.02 (0.94–1.10) .67
12 1.05 (0.99-1.13) .13 1.06 (0.92-1.22) .43 1.02 (0.86-1.21) .82 1.09 (0.94-1.26) .25 1.09 (0.95-1.23) .21
13 1.04 (0.98-1.10) .19 1.01 (0.89-1.15) .86 1.02 (0.87-1.18) .82 1.12 (0.98-1.27) .08 1.07 (0.96-1.19) .21
14 0.98 (0.94-1.02) .24 0.98 (0.90-1.07) .64 0.92 (0.82-1.03) .16 0.99 (0.90-1.09) .81 1.03 (0.95-1.11) .50
15 0.99 (0.95–1.05) .86 1.04 (0.94-1.16) .45 1.06 (0.94-1.20) .35 0.86 (0.76-0.98) .02 1.05 (0.96–1.16) .27
16 1.02 (0.97-1.08) .37 1.05 (0.94-1.17) .37 1.08 (0.94-1.23) .28 1.01 (0.90-1.14) .81 0.97 (0.88-1.07) .59
17 0.95 (0.90-1.00) .06 0.91 (0.81-1.03) .12 0.95 (0.82-1.09) .47 1.02 (0.91–1.15) .69 0.91 (0.82-1.02) .10
18 0.99 (0.95-1.04) .83 1.01 (0.92–1.11) .83 1.00 (0.89-1.13) .96 1.05 (0.96-1.15) .28 0.95 (0.86-1.04) .25
19 1.00 (0.96–1.05) .99 0.96 (0.88-1.06) .46 1.03 (0.92-1.16) .56 1.02 (0.92-1.12) .76 1.00 (0.92-1.09) .97
20 0.98 (0.94–1.02) .37 0.94 (0.85-1.03) .17 0.97 (0.87-1.08) .61 0.92 (0.83-1.02) .11 1.03 (0.95-1.13) .43
21 1.01 (0.97-1.05) .53 1.03 (0.95–1.11) .47 0.91 (0.80-1.03) .15 1.05 (0.97-1.14) .24 1.02 (0.95-1.10) .57
22 0.98 (0.94-1.02) .29 1.03 (0.96-1.11) .40 0.94 (0.84-1.04) .23 0.95 (0.87-1.03) .22 0.99 (0.92-1.06) .76
Note: Model included age, gender, country and all PCs; Figure 2 and Table S8 shows name and loading of individual variables in PCs.
Abbreviations: BCL, B-cell lymphoma; CIs, confidence intervals; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B-cell
lymphoma; FL, follicular lymphoma; HR, hazard ratios; MM, plasma cell neoplasm/multiple myeloma; PC, principal component.
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(inverse association) and risk of BCL. Many studies suggest that high-
fat diets are linked to the etiology of NHL. A recent meta-analysis
showed a significant association between total fat consumption and
increased risk of NHL and DLBCL, but not for CLL and FL.46 They
found that only high animal fat consumption increases the risk for
NHL with no association with vegetable fat consumption.46 A more
recent large prospective study, reported increased risk of NHL associ-
ated with intakes of total, animal, saturated and trans fat with
14 years of follow-up. However, these associations did not persist
with longer follow-up.47 Animal fats are comprised of saturated fatty
acids and unsaturated fats, whereas vegetable fat has a higher con-
centration of unsaturated fatty acids. A diet high in polyunsaturated
fatty acids has been shown to reduce the levels of pro-inflammatory
markers such as interleukin (IL)-6, IL-1 receptor antagonist, tumor
necrosis factor, and C-reactive protein, as well as increased levels of
anti-inflammatory factors, such as IL-10 and transforming growth fac-
tor.48 On the other hand, saturated fats can modulate immune func-
tion by enhancing nuclear factor-κB activation and antiapoptotic
behavior in T cells, in addition to increasing expression of pro-
inflammatory agents such as IL-6, cyclooxygenase-2 and inducible nit-
ric oxide synthase.39 A few studies suggest that the link might be
related to changes in serum levels of leptin and adiponectin that stim-
ulate proliferation and inhibit apoptosis through PI3K/AKT
activation.46
We previously showed that BCL risk was associated with a higher
ISD and a lower adherence to MD,24,26 which was confirmed in the
present study. The role of inflammation, immune dysregulation and
autoimmunity are known in the pathogenesis of lymphoma.49 Recent
studies further support the inflammatory potential of diet50; in partic-
ular, for lymphoid neoplasms, positive associations have been recently
reported between a pro-inflammatory dietary score and NHL.51 The
MD, one of the healthiest traditional dietary patterns, is a plant-based
pattern, where vegetables, fruits, cereals (preferably as whole grain),
legumes and nuts are consumed in high amount and frequency. It pro-
vides a diet rich in flavonoids, carotenoids and Vitamin C or E, whose
important antioxidant properties can neutralize free radicals or pre-
vent DNA damage.52,53
Moreover, our study suggests a possible beneficial effect of con-
diments and sauces intake on BCL and DLBCL. Spices, condiments
and sauces cover a broad range of substances with different charac-
teristics. Research indicates that some herbs and spices, or their bio-
active components, may act alone or in concert to reduce cancer risk
through their antimicrobial, antioxidant and antitumorigenic proper-
ties, as well as their direct suppressive effect on carcinogen
bioactivation. Nevertheless, the evidence to date with herbs and
spices is inconsistent and warrants greater attention.54
We found that physical activity (PC10) was positively associated
with BCL and DLBCL. Sex stratified analyses showed that the associa-
tion with DLBCL was limited to the female participants. It should be
noted that women reported lower levels of physical activity
(in general) and more household activity compared with men in our
study. However, it is not clear how physical activity positively influ-
ences DLBCL risk. Considering the increased risk of DLBCL for
manual work among women (Table S7), we cannot exclude bias due to
some unknown harmful co-exposures such as household pollutants
during physical activities to female participants. Our Cox regression
models also suggested a positive association between recreational
physical activity and DLBCL risk. Exposure to environmental pollut-
ants especially during outdoor recreational physical activity (ie, pas-
sive exposure to volatile organic compounds and other chemicals) also
cannot be excluded. The results of previous prospective investigations
are inconsistent, probably due to the lack of reliable, valid and com-
prehensive measures of physical activity.55 Despite of the relative
validity and reproducibility of the physical activity questions across
the countries in the EPIC study,20 some degree of measurement error
and misclassification is likely. Further studies that also incorporate
environmental and occupational exposures are needed.
Our study also suggests that heavy smoking (>25 per day) may
increase the risk of DLBCL. A pooled analysis of case-control studies
within the InterLymph consortium showed that current smoking was
associated with a significant 30% increased risk of FL, but not NHL
overall or other NHL subtypes.56 Moreover, a meta-analysis of seven
prospective studies57 did not show association between cigarette
smoking and NHL. Several factors may explain these inconsistencies
including methodological differences in the studies (ie, study design,
data collection, categorizations and residual confounding) and differ-
ences in population in terms of ethnicity, socioeconomic status, and
disease prevalence. Therefore, further research to pursue the associa-
tion is warranted. One promising direction for future investigation
includes refining our understanding of the carcinogens in cigarette
smoke and their biological effects that could plausibly contribute to
lymphomagenesis.58
An inverse association between alcohol intake and BCL has been
consistently observed in both large case-control2 and prospective
studies.59 However, it has been hypothesized that this association is
driven by unknown confounders. Unlike previous large observational
studies, our study did not show the protective effect of alcohol intake
in BCL. In contrast, our findings suggested a positive association
between alcohol intake (PC9) and FL among women after adjustment
for other PCs (HR = 1.24, 95% CI = 1.04-1.46) (Table 4). Due to insuf-
ficient power of the stratified analyses, this finding should be inter-
preted with caution and further prospective studies are deemed
necessary.
The LASSO analyses showed an inverse association between level
of education and risk of BCL. Limited and contradictory literature is
published about educational level or other SEP indicators and lym-
phoma risk.60,61 In line with our findings the InterLymph study
showed lower risk of lymphoma and DLBCL among highly educated
people.2 Populations with low SEP may be more exposed to hazard
occupational exposures, air pollution, smoking and infections which
can increase the risk of lymphoma.
Penalized Cox models revealed an inverse association between
history of hypertension and BCL. We recently reported also a nega-
tive association with hypertension and with both, systolic and dia-
stolic blood pressure levels in EPIC for all-type lymphomas and for the
subgroup of NHL.62 Inflammatory processes play an important role in
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the pathogenesis of hypertension. Different subpopulations of
immune cells involved in innate and adaptive immune responses are
involved in inflammatory processes and exert their effects in part via
production of various pro-inflammatory and anti-inflammatory
cytokines,63 so there may be some mechanistic explanation, but this
would need a more detailed investigation.
The strengths of this study include its prospective design, long
follow-up, and large size which allowed us to carry out analyses by
BCL subentities. Limitations of our study should be considered when
interpreting the results, including potential measurement errors
derived from questionnaires, which could lead to systematic and ran-
dom errors. We cannot rule out that they have affected risk estimates.
Our study lacked data on other exposures such as medication, occu-
pational exposures, family history of hematological cancers and medi-
cal history of immunologic disorders and viral infections which are
among the most important risk factors. In addition, we were unable to
take into account any possible changes in dietary and lifestyle habits
over time. Although reverse causation could be induced by changes of
lifestyle behaviors before recruitment because of early symptoms,
after exclusion of the first 2 years of follow-up, associations were
unchanged, possibly indicating a minor role of reverse causation.
Furthermore, despite the large number of observed incident cases
of BCL, this study might not have sufficient power to detect signifi-
cant associations within the BCL subtypes with a lower number of
cases, in particular in the sex and age stratified analyses. Finally,
despite multiple-testing corrections, we cannot exclude chance
findings.
In conclusion, our systematic evaluation confirmed several previ-
ously reported risk factors (anthropometric measures, animal fat, dairy
and sugar intake) as well as protective factors (MD, diet with lower
inflammatory score, fish and Vitamin D, SEP) of BCL and/or subtypes.
While our study did not support the previously reported protective
effect of alcohol intake on BCL, it revealed several unknown associa-
tions (increased risk of DLBCL with smoking and a beneficial effect of
condiments and sauces intake for BCL and DLBCL). In this study, we
applied a comprehensive approach for conceptualizing the roles and
relationships of multiple exposures in the etiology of BCL and could
generate some new insight in BCL risk factors. This highlights that tra-
ditional approaches of testing single association at a time could be
suboptimal compared with a EWAS approach.
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